Delving into the Latest Updates on Gamida Cell -Teva Joint Venture Ltd. with Synapse

Overview

A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects with Hematologic Malignancies following Myeloablative TherapyEstudio de control de cohortes histórico, internacional y multicéntrico para la evaluación de la eficacia y seguridad del transplante de StemEx®, hemocitoblastos de cordón umbilical y células progenitoras expandidas ex vivo, en pacientes que padecen neoplasias hematológicas, a continuación del tratamiento mielosupresor - ExCell

Start Date15 Apr 2008

Sponsor / Collaborator

Gamida Cell -Teva Joint Venture Ltd.

NCT00469729

/ CompletedPhase 2/3

A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx®, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects With Hematologic Malignancies Following Myeloablative Therapy

The purpose of this study is to determine the efficacy and safety of transplanting StemEx® in patients with certain hematological malignancies. For these patients, it is suggested that StemEx® can improve upon the outcome of transplanting a single, unmanipulated cord blood unit by significantly increasing the number of stem/progenitor cells available to the patient.

Start Date01 Oct 2007

Sponsor / Collaborator

Gamida Cell -Teva Joint Venture Ltd.

100 Clinical Results associated with Gamida Cell -Teva Joint Venture Ltd.

Login to view more data

0 Patents (Medical) associated with Gamida Cell -Teva Joint Venture Ltd.

Login to view more data

100 Deals associated with Gamida Cell -Teva Joint Venture Ltd.

Login to view more data

100 Translational Medicine associated with Gamida Cell -Teva Joint Venture Ltd.

Login to view more data